158 related articles for article (PubMed ID: 25872785)
1. Inhibition of TMEM45A suppresses proliferation, induces cell cycle arrest and reduces cell invasion in human ovarian cancer cells.
Guo J; Chen L; Luo N; Yang W; Qu X; Cheng Z
Oncol Rep; 2015 Jun; 33(6):3124-30. PubMed ID: 25872785
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of TMEM158 contributes to ovarian carcinogenesis.
Cheng Z; Guo J; Chen L; Luo N; Yang W; Qu X
J Exp Clin Cancer Res; 2015 Aug; 34(1):75. PubMed ID: 26239324
[TBL] [Abstract][Full Text] [Related]
3. EZH2 supports ovarian carcinoma cell invasion and/or metastasis via regulation of TGF-beta1 and is a predictor of outcome in ovarian carcinoma patients.
Rao ZY; Cai MY; Yang GF; He LR; Mai SJ; Hua WF; Liao YJ; Deng HX; Chen YC; Guan XY; Zeng YX; Kung HF; Xie D
Carcinogenesis; 2010 Sep; 31(9):1576-83. PubMed ID: 20668008
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of TMEM45A inhibits the proliferation, migration and invasion of glioma cells.
Sun W; Qiu G; Zou Y; Cai Z; Wang P; Lin X; Huang J; Jiang L; Ding X; Hu G
Int J Clin Exp Pathol; 2015; 8(10):12657-67. PubMed ID: 26722455
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of eIF4E suppresses cell proliferation, invasion and enhances cisplatin cytotoxicity in human ovarian cancer cells.
Wan J; Shi F; Xu Z; Zhao M
Int J Oncol; 2015 Dec; 47(6):2217-25. PubMed ID: 26498997
[TBL] [Abstract][Full Text] [Related]
6. TMEM45A Affects Proliferation, Apoptosis, Epithelial-Mesenchymal Transition, Migration, Invasion and Cisplatin Resistance of HPV-Positive Cervical Cancer Cell Lines.
Liu Y; Liu L; Mou ZX
Biochem Genet; 2022 Feb; 60(1):173-190. PubMed ID: 34143331
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of microtubule-associated protein 1 light chain 3B via small-interfering RNA or 3-methyladenine impairs hypoxia-induced HO8910PM and HO8910 epithelial ovarian cancer cell migration and invasion and is associated with RhoA and alterations of the actin cytoskeleton.
Tang Z; Zhang N; Di W; Li W
Oncol Rep; 2015 Mar; 33(3):1411-7. PubMed ID: 25607473
[TBL] [Abstract][Full Text] [Related]
8. COL11A1 promotes tumor progression and predicts poor clinical outcome in ovarian cancer.
Wu YH; Chang TH; Huang YF; Huang HD; Chou CY
Oncogene; 2014 Jun; 33(26):3432-40. PubMed ID: 23934190
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Proliferation, Migration, and Invasion by Knockdown of Pyruvate Kinase-M2 (PKM2) in Ovarian Cancer SKOV3 and OVCAR3 Cells.
Miao Y; Lu M; Yan Q; Li S; Feng Y
Oncol Res; 2016 Oct; 24(6):463-475. PubMed ID: 28281967
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of TMEM14A expression by RNAi inhibits the proliferation and invasion of human ovarian cancer cells.
Zhang Q; Chen X; Zhang X; Zhan J; Chen J
Biosci Rep; 2016; 36(1):e00298. PubMed ID: 26896463
[TBL] [Abstract][Full Text] [Related]
11. The role of Sox6 and Netrin-1 in ovarian cancer cell growth, invasiveness, and angiogenesis.
Li Y; Xiao M; Guo F
Tumour Biol; 2017 May; 39(5):1010428317705508. PubMed ID: 28475012
[TBL] [Abstract][Full Text] [Related]
12. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y
Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143
[TBL] [Abstract][Full Text] [Related]
13. [Correlation of expression of RhoA (RhoC and their effector ROCK-1 with malignant phenotype of ovarian cancer cells in vitro].
Han ZQ; Zhang AL; Wu MF; Liu YL; Chen G; Li FJ; Gao QL; Liao GN; Lu YP; Wang SX; Ma D
Zhonghua Zhong Liu Za Zhi; 2004 Jul; 26(7):385-8. PubMed ID: 15355639
[TBL] [Abstract][Full Text] [Related]
14. ARHGAP10, downregulated in ovarian cancer, suppresses tumorigenicity of ovarian cancer cells.
Luo N; Guo J; Chen L; Yang W; Qu X; Cheng Z
Cell Death Dis; 2016 Mar; 7(3):e2157. PubMed ID: 27010858
[TBL] [Abstract][Full Text] [Related]
15. TMEM45B, up-regulated in human lung cancer, enhances tumorigenicity of lung cancer cells.
Hu R; Hu F; Xie X; Wang L; Li G; Qiao T; Wang M; Xiao H
Tumour Biol; 2016 Sep; 37(9):12181-12191. PubMed ID: 27225290
[TBL] [Abstract][Full Text] [Related]
16. Lentivirus-mediated shRNA interference of clusterin blocks proliferation, motility, invasion and cell cycle in the ovarian cancer cells.
Fu Y; Lai Y; Liu J; Liu X; You Z; Yang G
J Ovarian Res; 2015 Aug; 8():59. PubMed ID: 26293319
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of RhoA/Rho-kinase pathway suppresses the expression of type I collagen induced by TGF-beta2 in human retinal pigment epithelial cells.
Itoh Y; Kimoto K; Imaizumi M; Nakatsuka K
Exp Eye Res; 2007 Mar; 84(3):464-72. PubMed ID: 17217948
[TBL] [Abstract][Full Text] [Related]
18. TMEM49-related apoptosis and metastasis in ovarian cancer and regulated cell death.
Zheng L; Chen L; Zhang X; Zhan J; Chen J
Mol Cell Biochem; 2016 May; 416(1-2):1-9. PubMed ID: 27023910
[TBL] [Abstract][Full Text] [Related]
19. [Inhibitory effects of RNA interference on expression of matrix metalloproteinase-9 gene and invasiveness and adhesion in ovarian cancer cells].
Hu XX; Li L; Li DR; Zhang W; Tang BJ
Zhonghua Fu Chan Ke Za Zhi; 2006 Sep; 41(9):579-83. PubMed ID: 17181964
[TBL] [Abstract][Full Text] [Related]
20. Targeting HMGB1 inhibits ovarian cancer growth and metastasis by lentivirus-mediated RNA interference.
Chen J; Liu X; Zhang J; Zhao Y
J Cell Physiol; 2012 Nov; 227(11):3629-38. PubMed ID: 22331597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
